FDA Adverse Event Malfunction Summary report: N

0.8% RESOLVE PANEL A

MDR report key: 1140404 · Received June 12, 2008

Report

Report Number
2250051-2008-70303
Event Type
Malfunction
Date Received
June 12, 2008
Date of Event
May 22, 2008
Report Date
June 12, 2008
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
KSZ
Product Problem
Yes
Report Source
Distributor report
Reporter Location
NJ, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Description of Event or Problem · 1

CUSTOMER REPORTED NO REACTIVITY WITH VRA115 CELLS 2 AND 7 (JKA-B+) AND A PT SAMPLE CONTAINING ANTI-JKB. CUSTOMER STATED THAT THE ANTIBODY SCREEN WAS POSITIVE, HOWEVER, ONLY VRA115 CELL 5 REACTED. ADD'L TESTING WAS PERFORMED AND AN ANTI-JKB SHOWING DOSAGE WAS IDENTIFIED. CUSTOMER REVIEWED RESULTS WITH VRA1115 AND OBSERVED THAT CELLS 2 AND 7 WERE JKA-B+ AND DID NOT REACT. CUSTOMER STATED NO REPORTS OF ANY DISCREPANCIES WITH ANY OTHER PTS OR WITH QC TESTING. NO ERRONEOUS RESULTS WERE REPORTED. NO DEATH OR SERIOUS INJURY WAS ASSOCIATED WITH THIS INCIDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 0.8% RESOLVE PANEL A REAGENT RED BLOOD CELLS KSZ ORTHO-CLINICAL DIAGNOSTICS NA VRA1115

Patients

Seq Age Sex Outcome Treatment
1 *